Boston Scientific Corporation announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS(R) Express2(TM) paclitaxel-eluting coronary stent system in Japan.
World-class cancer researchers whose science has significantly contributed to progress in the fight against cancer will be recognized April 14-18, 2007, by the American Association for Cancer Research (AACR) at its 2007 Annual Meeting in Los Angeles, Calif.
Souplantation announced it is cooperating with the Orange County Health Care Agency in an investigation of a confirmed E.coli outbreak at its Foothill Ranch restaurant located at 26572 Towne Center Drive, Lake Forest, CA 92610.
Novavax Inc.’s virus-like particle (VLP) vaccine triggered a robust immune response and provided protection against the H9N2 strain of avian influenza, according to pre-clinical data published in the online edition of the journal Vaccine.
GlaxoSmithKline K.K. (Head Office: Shibuya-ku, Tokyo, President: Marc Dunoyer, hereinafter referred to as GSK) announced the submission of a New Drug Application (NDA) to the Japanese authorities for approval to market lapatinib, its new cancer drug on 30 March.
A new medical device in development by University of Cincinnati researchers may sniff out olfactory disorders that could be an early warning of Alzheimer?s disease, Parkinson?s disease and other problems outside the typical sensory loss associated with aging.
Cephalon, Inc. (Nasdaq: CEPH) announced that it has received an approvable letter, together with draft labeling, from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) for NUVIGIL(TM) (armodafinil) Tablets [C-IV] for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS) and shift work sleep disorder (SWSD).
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) and Harvard Medical School has identified seven genetic risk factors?DNA sequences carried by some people but not others?that predict risk for prostate cancer.
The Food and Drug Administration (FDA) notified Hill’s Pet Nutrition, Inc., of Topeka, Kansas, that FDA testing has detected melamine and melamine byproducts in wheat gluten received by the company to make dry cat food.
The U.S. Food and Drug Administration (FDA) licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.